Search research articles
Contact Us
Filters
Showing results (221-230 of 233) with videos related to
Page
of 24
Sort By:
Neurology
|
August 13, 2017
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review
Michael K Hehir, Lisa D Hobson-Webb, Michael Benatar, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 13, 2018
Indications for neuromuscular ultrasound: Expert opinion and review of the literature
Francis O Walker, Michael S Cartwright, Katharine E Alter, et al.
Journal of Medicinal Chemistry
|
April 14, 2023
Correction to "Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads"
Adrian D Hobson, Michael J McPherson, Wendy Waegell, et al.
Advanced Therapeutics
|
October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies
John W Rumsey, Case Lorance, Max Jackson, et al.
Journal of Medicinal Chemistry
|
February 8, 2022
Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads
Adrian D Hobson, Michael J McPherson, Wendy Waegell, et al.
Muscle & Nerve
|
December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis
Katherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Journal of Medicinal Chemistry
|
September 1, 2023
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D Hobson, Jianwen Xu, Dennie S Welch, et al.
Journal of Medicinal Chemistry
|
December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
Justin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
Science Translational Medicine
|
March 20, 2024
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
Michael J McPherson, Adrian D Hobson, Axel Hernandez, et al.
Journal of Medicinal Chemistry
|
April 7, 2023
Correction to "Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate"
Adrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 233) with videos related to
Sort By:
Page
of 24
Neurology
|
August 13, 2017
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review
Michael K Hehir, Lisa D Hobson-Webb, Michael Benatar, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 13, 2018
Indications for neuromuscular ultrasound: Expert opinion and review of the literature
Francis O Walker, Michael S Cartwright, Katharine E Alter, et al.
Journal of Medicinal Chemistry
|
April 14, 2023
Correction to "Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads"
Adrian D Hobson, Michael J McPherson, Wendy Waegell, et al.
Advanced Therapeutics
|
October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies
John W Rumsey, Case Lorance, Max Jackson, et al.
Journal of Medicinal Chemistry
|
February 8, 2022
Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads
Adrian D Hobson, Michael J McPherson, Wendy Waegell, et al.
Muscle & Nerve
|
December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis
Katherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Journal of Medicinal Chemistry
|
September 1, 2023
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D Hobson, Jianwen Xu, Dennie S Welch, et al.
Journal of Medicinal Chemistry
|
December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
Justin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
Science Translational Medicine
|
March 20, 2024
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
Michael J McPherson, Adrian D Hobson, Axel Hernandez, et al.
Journal of Medicinal Chemistry
|
April 7, 2023
Correction to "Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate"
Adrian D Hobson, Michael J McPherson, Martin E Hayes, et al.
Page
of 24